Caught in a web?

Woman Sues Johnson & Johnson in Potential $1.7 Billion Class Action Over Prolift Transvaginal Mesh InjuriesA woman has just filed a lawsuit over the Johnson & Johnson Prolift mesh transvaginal mesh device over claims that, among other issues, the device was sold without U.S. Food and Drug Administration (FDA) approval.The lawsuit was brought in the District Court in Lod, Israel, on behalf of the plaintiff and with a request for the court to certify the claim as a class action suit for NIS 6 billion—or about $1.7 billion—on behalf of about 60,000 women in Israel who allegedly experienced similar injuries tied to the Prolift mesh, according to Jewish Business News.The female plaintiff alleges that, in August 2006, she underwent a surgical procedure to relieve vaginal pain and was implanted with the Prolift mesh. The court documents indicate that, since 1996, there have reports involving women worldwide who have been implanted with the Prolift mesh who suffered from an array of injuries, including profuse vaginal discharge and related physical damage, such as bleeding, bed sores, recurring infection, perforation of the urinary tract during implantation, incontinence, and severe pain, Jewish Business News reported.The lawsuit claims that the Prolift mesh has been marketed since March 2005, including in Israel, without FDA approval, and that, in March 2012, the FDA issued a statement that Johnson & Johnson marketed the Prolift without agenc...

Source: PharmaGossip - October 17, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs